Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remission.
暂无分享,去创建一个
P. Wolkenstein | E. Sbidian | O. Chosidow | T. Duong | J. Papon | É. Béquignon | A. Coste | S. Ingen-Housz-Oro | Véronique Chatelin | L. Valeyrie‐Allanore | É. Sbidian | E. Sbidian
[1] C. Brun-Buisson,et al. Acute Respiratory Failure in Patients With Toxic Epidermal Necrolysis: Clinical Features and Factors Associated With Mechanical Ventilation* , 2014, Critical care medicine.
[2] R. Lefering,et al. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents. , 2013, Burns : journal of the International Society for Burn Injuries.
[3] L. Naldi,et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2013, The Journal of investigative dermatology.
[4] Somchai Yongsiri,et al. Characteristics of toxic epidermal necrolysis and Stevens-Johnson syndrome: a 5-year retrospective study. , 2013, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[5] B. Pollock,et al. Toxic epidermal necrolysis: five years of treatment experience from a burn unit. , 2012, Journal of the American Academy of Dermatology.
[6] R. Zajíček,et al. Toxic epidermal necrolysis and Stevens‐Johnson syndrome at the Prague Burn Centre 1998–2008 , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[7] H. Benchikhi,et al. [Stevens-Johnson and Lyell syndromes: mucocutaneous and ocular sequels in 43 cases]. , 2011, Annales de dermatologie et de venereologie.
[8] N. Moiemen,et al. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre , 2010, Clinical and experimental dermatology.
[9] J. Roujeau,et al. Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis , 2010, The British journal of dermatology.
[10] A. Dunant,et al. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis , 2010, Clinical pharmacology and therapeutics.
[11] J. Roujeau,et al. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. , 2009, Archives of Dermatology.
[12] G. Soubrane,et al. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2009, Archives of dermatology.
[13] L. Naldi,et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. , 2002, Archives of dermatology.
[14] J. Roujeau,et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. , 2000, The Journal of investigative dermatology.
[15] J. Roujeau,et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? , 2000, Archives of dermatology.
[16] J. Roujeau,et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study , 1997, Intensive Care Medicine.
[17] J. Roujeau,et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. , 1995, Archives of dermatology.
[18] Michael Stewart,et al. Head and Neck Manifestations of Erythema Multiforme in Children , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[19] W. Koch,et al. Stevens-Johnson syndrome with supraglottic laryngeal obstruction. , 1989, Archives of otolaryngology--head & neck surgery.
[20] J. Parsons. Management of toxic epidermal necrolysis. , 1985, Cutis.
[21] Y. Tay,et al. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes. , 2012, Acta dermato-venereologica.
[22] H. Benchikhi,et al. [Stevens-Johnson and Lyell syndromes: mucocutaneous and ocular sequels in 43 cases]. , 2011, Annales de dermatologie et de venereologie.
[23] M. Mockenhaupt,et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. , 2008, Journal of the American Academy of Dermatology.
[24] L. Naldi,et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. , 2008, The Journal of investigative dermatology.
[25] R. Rogers,et al. Oral manifestations of erythema multiforme. , 2003, Dermatologic clinics.
[26] R. Stern,et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. , 1993, Archives of dermatology.